Top

Actinium-225 (Ac-225) Supply

Scalable Actinium-225 supply for clinical and commercial success

Eckert & Ziegler is establishing one of the world’s first commercial, GMP-compliant production lines for Actinium-225. With our validated cyclotron-based process and global infrastructure, we are committed to supporting radiopharmaceutical developers and manufacturers as they advance targeted alpha therapies from bench to bedside. 
Production is currently being scaled up, with GMP-grade Ac-225 expected to be available starting in Q3 2025. Secure your supply early and partner with a trusted leader in radioisotope innovation.

Key Features

Coming Soon: First GMP-grade lots from our facilities will be available in Q3 2025. Secure your access now!
Long-Term Partnerships: Supporting your full development cycle with secure supply and collaborative services. 

Actinium-225 Detail Information

Production Process

Our production uses a proprietary cyclotron-based method, irradiating Radium-226 targets to produce non-carrier-added Actinium-225. This innovative technology in combination with an extensive purification process enables highly pure Ac-225 with minimal contaminations of long-lived isotopes—ideal for therapeutic use. Operations are being validated for GMP compliance with first certified batches expected in Q3 2025.

Applications

Our Actinium-225 is suitable for radiolabeling peptides, antibodies, and small molecules used in the development of targeted alpha therapies for oncology and beyond. It supports applications in early-phase research, and GMP material will be available soon for late-stage trials and commercial deployment.

Supply & Logistics

With a central European production hub and a global logistics network, we offer flexible delivery, secure transport, and full regulatory support. Early reservation options and scalable output help you stay ahead of clinical and commercial demand.

Beyond Supply

Eckert & Ziegler also offers CDMO services, hot cell solution and synthesis as well as quality control equipment to streamline your path from isotope to finished product. Our expertise covers the full alpha therapy value chain. Learn more about our alpha expertise! >>>

Product specific questions?

Eckert & Ziegler
Medical
Robert-Rössle-Str.10
13125 Berlin
Germany

+49 30 94 10 84 0
+49 30 94 10 84 470
The Medical Bulletin Subscribe and stay updated

Are you interested in receiving the latest news on our products and recent developments? Do you want to stay updated regarding upcoming events? Our newsletter will be sent regularly and you can unsubscribe anytime.

Email Lists (please select at least one)

SUBSCRIBE TO OUR NEWSLETTER

WordPress Cookie Plugin by Real Cookie Banner